Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women.

about

Factors associated with time to achieve an undetectable HIV RNA viral load after start of antiretroviral treatment in HIV-1-infected pregnant women.

Item

http://www.wikidata.org/entity/Q42318291

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Factors associated with time t ...... HIV-1-infected pregnant women.

@en

Factors associated with time t ...... HIV-1-infected pregnant women.

@nl

type

Item

label

Factors associated with time t ...... HIV-1-infected pregnant women.

@en

Factors associated with time t ...... HIV-1-infected pregnant women.

@nl

prefLabel

Factors associated with time t ...... HIV-1-infected pregnant women.

@en

Factors associated with time t ...... HIV-1-infected pregnant women.

@nl

P1476

Factors associated with time t ...... HIV-1-infected pregnant women.

@en

P2093

Amj Wensing

http://www.w3.org/2001/XMLSchema#string

C Smit

http://www.w3.org/2001/XMLSchema#string

Fjb Nellen

http://www.w3.org/2001/XMLSchema#string

M H Godfried

http://www.w3.org/2001/XMLSchema#string

T Mudrikova

http://www.w3.org/2001/XMLSchema#string

W Snippenburg

http://www.w3.org/2001/XMLSchema#string

P2860

Pregnancy and virologic response to antiretroviral therapy in South Africa

Kinetics and determining factors of the virologic response to antiretrovirals during pregnancy.

Risk factors for detectable HIV-1 RNA at delivery among women receiving highly active antiretroviral therapy in the women and infants transmission study.

Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy)

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.

Risk factors for pre-term birth in a Canadian cohort of HIV-positive women: role of ritonavir boosting?

Characteristics associated with suboptimal viral suppression at delivery in human immunodeficiency virus-1-infected pregnant women.

Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy.

Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load <500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1).

When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?

P304

34-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28275456

http://www.w3.org/2001/XMLSchema#string

P921

7bèla

viral load

P932

5337419

http://www.w3.org/2001/XMLSchema#string